- Bio relevant in-vitro tests to understand in vitro behavior of products and development of IVIVC/R.
- Bio study strategy comprising of suitable study design, sampling points, protocol and number of volunteers.
- BA/BE studies involving in vitro end points, PD end points, special population and patients.
- Bio waiver strategy, BCS class approach for ANDA approval, highly variable drugs & drug products
